France
Chipiron, founded in 2020 and headquartered in France, is pioneering advancements in the healthcare industry by developing next-generation MRI machines. With the compelling slogan, "Shaping the future of Healthcare by building the next-gen of MRI machines," Chipiron aims to empower wider community access to MRI technology.
The company is addressing a critical need by creating the first lightweight, cost-effective MRI machines capable of operating at ultra-low magnetic fields without sacrificing image quality. By making MRI technology 100 times more accessible, Chipiron aspires to transform healthcare through broader applications and earlier disease detection, potentially elevating MRI usage to be as routine as blood sampling.
Recently, Chipiron secured a €14.90M Series A investment on April 30, 2025, with funders including Unruly Capital, Blast, EIC Fund, iXcore, and Exor Ventures. This investment underscores strong investor confidence in Chipiron's mission and its potential impact on the healthcare landscape.
